Brief: Biofrontera AG Says Decides To Delist ADS From Nasdaq To Reduce Complexity And Costs
14/02/2022 19:10
Feb 14 (Reuters) - Biofrontera AG B8FGn.DE :
* PTA-ADHOC: BIOFRONTERA AG: BIOFRONTERA AG DECIDES TO
DELIST ADS
FROM NASDAQ TO REDUCE COMPLEXITY AND COSTS
* MAIN PURPOSE OF DELISTING IS TO REDUCE COMPLEXITY IN
FINANCIAL
REPORTING AND ADMINISTRATIVE COSTS
* BIOFRONTERA AG'S ORDINARY SHARES WILL CONTINUE TO TRADE IN
PRIME
STANDARD AT DEUTSCHE BÖRSE UNDER SYMBOL B8F
* PLANS TO SUBMIT A FORM 25 RELATING TO ITS ADSS ON NASDAQ
TO SEC
ON OR ABOUT FEBRUARY 24, 2022 TO INITIATE DELISTING
* EXPECTS DELISTING TO BE BECOME EFFECTIVE NOT LESS THAN TEN
DAYS
AFTER FEB 24
Source text for Eikon: ID:nPexKPh9na
Further company coverage: B8FGn.DE
((reuters.briefs@thomsonreuters.com;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million